Lori J. Braender, General Counsel at Aquestive Therapeutics, Inc. (AQST), bought 13,761 shares at $0.96 ($13K) on 2022-06-08, disclosed to the SEC on 2022-06-10.
Open-market purchase of $13k AQST by General Counsel. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade B.
Clearly above the average filing.
| Filing → |
| AQST | BUY | 2019-08-13 | $41K | — | Filing → |
| AQST | BUY | 2018-11-29 | $11K | — | Filing → |